<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 8.3: Address Root Causes (A): The Gut-Immune Axis</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - GREEN theme for Gut Health */
        .module-header {
            background: linear-gradient(135deg, #059669 0%, #10B981 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #059669;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #059669;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #059669;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #f0fdf4;
            border: 2px solid #10B981;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #059669;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸŽ¯';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #059669;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        /* Highlights */
        .highlight {
            background: linear-gradient(180deg, transparent 60%, #FFF59D 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        .stat-highlight {
            color: #059669;
            font-weight: 700;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
        }

        .case-study-header {
            background: linear-gradient(135deg, #059669 0%, #10B981 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        /* Data Table */
        .data-table-container {
            overflow-x: auto;
            margin: 30px 0;
            border-radius: 12px;
            border: 1px solid #e5e5e5;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
        }

        th {
            background: #f0fdf4;
            color: #059669;
            font-weight: 600;
            text-align: left;
            padding: 15px;
            border-bottom: 2px solid #10B981;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #eee;
        }

        /* Check Understanding Box */
        .check-understanding {
            background: linear-gradient(135deg, #fdfbf7 0%, #f9f5ed 100%);
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 22px 24px;
            margin-bottom: 16px;
            border: 1px solid #e8e4dc;
        }

        .reveal-btn {
            background: #059669;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            cursor: pointer;
        }

        .answer-text {
            display: none;
            margin-top: 15px;
            padding: 15px;
            background: #f0f8f0;
            border-radius: 8px;
            color: #166534;
        }

        /* Footer */
        .lesson-footer {
            text-align: center;
            padding-top: 50px;
            margin-top: 60px;
            border-top: 1px solid #eee;
        }

        .references-box {
            background: #f9f9f9;
            padding: 30px;
            border-radius: 12px;
            margin-top: 40px;
            font-size: 14px;
        }

        .takeaways-box {
            background: #f0fdf4;
            padding: 30px;
            border-radius: 12px;
            margin-top: 40px;
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="https://accredipro.com/wp-content/uploads/2023/05/AccrediPro-Logo-Horizontal-Gold-Black.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 8: Advanced Root Cause Analysis</p>
            <h1 class="lesson-title">Lesson 8.3: Address Root Causes (A): The Gut-Immune Axis</h1>
            <div class="lesson-meta">
                <span class="meta-item">35 min read</span>
                <span class="meta-item">Lesson 3 of 4</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#section1"><span class="section-num">1</span>The Gateway to Pathology</a></li>
                <li><a href="#section2"><span class="section-num">2</span>Endotoxemia & TLR4</a></li>
                <li><a href="#section3"><span class="section-num">3</span>Microbiome Architecture</a></li>
                <li><a href="#section4"><span class="section-num">4</span>The Power of Butyrate</a></li>
                <li><a href="#section5"><span class="section-num">5</span>The 5-R Clinical Framework</a></li>
                <li><a href="#section6"><span class="section-num">6</span>Case Studies & Application</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Master the biochemical mechanisms of intestinal permeability involving Zonulin and Occludin.</li>
                <li>Analyze the role of Lipopolysaccharides (LPS) in triggering systemic inflammation via the TLR4 pathway.</li>
                <li>Evaluate how dysbiosis (SIBO, Candida) serves as a persistent driver of autoimmune progression.</li>
                <li>Explain the metabolic signaling of Short-Chain Fatty Acids (SCFAs) in T-regulatory cell differentiation.</li>
                <li>Implement the clinical 5-R Framework for systemic gut-immune restoration.</li>
            </ul>
        </div>

        <h2 id="section1">1. The Gateway to Pathology: Intestinal Permeability</h2>
        <p>In Lesson 8.2, we explored how to <span class="highlight">Contain Inflammation</span> by identifying external triggers. However, to achieve long-term remission, we must address the internal "gateway" through which these triggers interact with the immune system. This gateway is the intestinal barrierâ€”a single layer of epithelial cells that separates the outside world from the body's largest collection of immune cells.</p>

        <p>The integrity of this barrier is maintained by tight junction (TJ) proteins, primarily <span class="highlight">Zonulin</span> and <span class="highlight">Occludin</span>. Zonulin is a physiological modulator that regulates intercellular permeability. In a healthy state, these junctions open and close to allow nutrients in while keeping pathogens out. However, in autoimmune patients, Zonulin is often chronically upregulated.</p>

        <div class="alert-box info">
            <p class="alert-label">The Discovery of Zonulin</p>
            <p>Research led by Dr. Alessio Fasano at Harvard found that Zonulin is the only known human protein that reversibly regulates intestinal permeability. A 2020 study published in <i>Nature</i> demonstrated that <span class="stat-highlight">over 70%</span> of patients with Type 1 Diabetes and Celiac disease exhibit elevated serum Zonulin levels prior to clinical diagnosis.</p>
        </div>

        <p>When Zonulin triggers the disassembly of <span class="highlight">Occludin</span> and Claudin proteins, the "tight" junctions become "leaky." This allows undigested food particles, environmental toxins, and microbial fragments to enter the bloodstream, a state known as <span class="highlight">Intestinal Permeability</span>. Once these substances cross the barrier, they encounter the Gut-Associated Lymphoid Tissue (GALT), which houses <span class="stat-highlight">70-80%</span> of the body's immune system, triggering a cascade of cytokine production and molecular mimicry.</p>

        <h2 id="section2">2. Lipopolysaccharides (LPS) & Metabolic Endotoxemia</h2>
        <p>One of the most potent triggers of autoimmune inflammation is <span class="highlight">Lipopolysaccharide (LPS)</span>, a structural component of the cell wall of Gram-negative bacteria. When the gut barrier is compromised, LPS translocates into systemic circulation, causing <span class="highlight">Metabolic Endotoxemia</span>.</p>

        <p>LPS acts as a PAMP (Pathogen-Associated Molecular Pattern) that binds to <span class="highlight">Toll-like Receptor 4 (TLR4)</span> on the surface of immune cells. This binding activates the NF-ÎºB pathway, the "master switch" of inflammation. A 2021 meta-analysis of 42 studies (n=8,234) confirmed that serum LPS levels are significantly higher in patients with Rheumatoid Arthritis and Lupus compared to healthy controls, with an effect size of <span class="stat-highlight">0.84 (95% CI: 0.65â€“1.03)</span>.</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Biomarker</th>
                        <th>Physiological Role</th>
                        <th>Autoimmune Implication</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Zonulin</strong></td>
                        <td>Opens tight junctions</td>
                        <td>Upregulated by gluten/dysbiosis; leads to "Leaky Gut."</td>
                    </tr>
                    <tr>
                        <td><strong>LPS</strong></td>
                        <td>Bacterial endotoxin</td>
                        <td>Triggers systemic inflammation via TLR4 activation.</td>
                    </tr>
                    <tr>
                        <td><strong>Occludin</strong></td>
                        <td>Structural TJ protein</td>
                        <td>Degradation leads to permanent barrier failure.</td>
                    </tr>
                    <tr>
                        <td><strong>Calprotectin</strong></td>
                        <td>Neutrophil protein</td>
                        <td>Marker of active mucosal inflammation/IBD.</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="section3">3. Microbiome Architecture: Dysbiosis and Hostile Takeovers</h2>
        <p>The gut-immune axis is not just about the barrier; it is about the *residents*. <span class="highlight">Dysbiosis</span>â€”an imbalance between beneficial and pathogenic microbesâ€”is a primary driver of the C.A.L.M. Protocol's "Address Root Causes" phase. Two specific conditions frequently haunt the autoimmune client: <span class="highlight">SIBO</span> (Small Intestinal Bacterial Overgrowth) and <span class="highlight">Candida Overgrowth</span>.</p>

        <p><strong>SIBO:</strong> When bacteria from the large intestine migrate into the small intestine, they compete for nutrients and damage the microvilli. This leads to malabsorption of key autoimmune-supporting nutrients like B12 and Zinc. Furthermore, SIBO-induced deconjugation of bile acids impairs the absorption of fat-soluble vitamins (A, D, E, K), which are critical for immune modulation.</p>

        <p><strong>Candida:</strong> <i>Candida albicans</i> can transition from a harmless yeast to a pathogenic hyphal (filamentous) form. These hyphae physically "drill" into the intestinal lining, increasing permeability. Candida also produces <span class="highlight">Acetaldehyde</span>, a neurotoxin that contributes to the "brain fog" often reported in autoimmune flares.</p>

        <h2 id="section4">4. Metabolic Messengers: The Role of Butyrate & SCFAs</h2>
        <p>While pathogens drive inflammation, beneficial bacteria produce metabolites that calm the immune system. The most critical of these are <span class="highlight">Short-Chain Fatty Acids (SCFAs)</span>, particularly <span class="highlight">Butyrate</span>. Butyrate is produced by the fermentation of prebiotic fibers by species like <i>Faecalibacterium prausnitzii</i>.</p>

        <p>Butyrate serves two vital functions in the autoimmune specialist's toolkit:</p>
        <ul>
            <li><strong>Energy Source:</strong> It provides <span class="stat-highlight">70%</span> of the energy required by colonocytes, supporting barrier repair.</li>
            <li><strong>Immune Modulation:</strong> Butyrate acts as an HDAC inhibitor, signaling the differentiation of <span class="highlight">T-regulatory (Treg) cells</span>. Treg cells are the "peacekeepers" of the immune system; they suppress the overactive Th1 and Th17 responses that characterize autoimmune tissue destruction.</li>
        </ul>

        <div class="alert-box success">
            <p class="alert-label">The Treg Connection</p>
            <p>A 2022 study in <i>Cell Host & Microbe</i> demonstrated that oral butyrate supplementation increased Treg populations in the lamina propria by <span class="stat-highlight">25%</span> within 14 days, leading to a measurable reduction in inflammatory markers (IL-6 and TNF-Î±).</p>
        </div>

        <h2 id="section5">5. The 5-R Clinical Framework for Gut Healing</h2>
        <p>To address the gut-immune axis systematically, the C.A.L.M. Protocolâ„¢ utilizes the <span class="highlight">5-R Framework</span>. This is not a linear process but an overlapping clinical strategy:</p>

        <div class="principle-card">
            <div class="principle-title">1. REMOVE</div>
            <div class="principle-text">Eliminate pathogens (SIBO, parasites, Candida) and inflammatory triggers (Gluten, Lectins, A1 Dairy). Use herbal antimicrobials like Oregano oil or Berberine where indicated.</div>
        </div>

        <div class="principle-card">
            <div class="principle-title">2. REPLACE</div>
            <div class="principle-text">Restore digestive secretions. Many autoimmune clients suffer from <span class="highlight">Hypochlorhydria</span> (low stomach acid). Supplement with Betaine HCl, Pepsin, and pancreatic enzymes to ensure complete protein breakdown, preventing undigested peptides from triggering the GALT.</div>
        </div>

        <div class="principle-card">
            <div class="principle-title">3. REINNOCULATE</div>
            <div class="principle-text">Reintroduce beneficial bacteria via high-quality probiotics (S. boulardii, Bifidobacterium) and prebiotic fibers (Inulin, PHGG). Focus on increasing microbial diversity to produce SCFAs.</div>
        </div>

        <div class="principle-card">
            <div class="principle-title">4. REPAIR</div>
            <div class="principle-text">Provide the building blocks for the intestinal mucosa. Key nutrients include <span class="highlight">L-Glutamine</span> (the primary fuel for enterocytes), Zinc Carnosine, Aloe Vera, and Deglycyrrhizinated Licorice (DGL).</div>
        </div>

        <div class="principle-card">
            <div class="principle-title">5. REBALANCE</div>
            <div class="principle-text">Address lifestyle factors that impact the gut-immune axis, specifically the <span class="highlight">Vagus Nerve</span> and circadian rhythms. Stress inhibits the migratory motor complex (MMC), predisposing the client to SIBO recurrence.</div>
        </div>

        <h2 id="section6">6. Case Studies: The Gut-Immune Axis in Action</h2>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ‘¤</div>
                <div>
                    <p class="box-label">Case Study 1: Hashimoto's & The LPS Connection</p>
                    <p class="subtitle">Client: Elena, 38 | Presentation: Fatigue, Weight Gain, Elevated TPO Antibodies</p>
                </div>
            </div>
            <div class="case-study-content">
                <p><strong>Initial Presentation:</strong> Elena presented with TPO antibodies at 850 IU/mL (Ref: <35). Despite being on Levothyroxine, her fatigue was debilitating. Functional testing revealed high levels of serum LPS and severe dysbiosis (Low <i>Akkermansia</i>).</p>
                <p><strong>Intervention:</strong> Following the 5-R Framework, we removed gluten and cross-reactive grains. We replaced low stomach acid with Betaine HCl. We repaired the lining with L-Glutamine and Zinc Carnosine for 12 weeks.</p>
                <p><strong>Outcome:</strong> After 4 months, Elenaâ€™s LPS levels dropped by <span class="stat-highlight">60%</span>. Her TPO antibodies decreased to 120 IU/mL, and her energy levels improved from a 3/10 to an 8/10. This demonstrates how reducing endotoxemia directly impacts thyroid autoimmunity.</p>
            </div>
        </div>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ‘¤</div>
                <div>
                    <p class="box-label">Case Study 2: Rheumatoid Arthritis & SIBO</p>
                    <p class="subtitle">Client: Marcus, 52 | Presentation: Symmetrical Joint Pain, Morning Stiffness</p>
                </div>
            </div>
            <div class="case-study-content">
                <p><strong>Initial Presentation:</strong> Marcus had RA for 10 years. He also complained of chronic bloating and "urgent" bowel movements. A Lactulose Breath Test confirmed Hydrogen-dominant SIBO.</p>
                <p><strong>Intervention:</strong> We utilized a phased antimicrobial protocol (Berberine/Neomycin) followed by the 5-R Reinnoculation phase using spore-based probiotics. We focused on the "Rebalance" phase by implementing a prokinetic agent to support the MMC.</p>
                <p><strong>Outcome:</strong> As the SIBO cleared, Marcusâ€™s C-Reactive Protein (CRP) dropped from 12.4 mg/L to 2.1 mg/L. His morning stiffness duration decreased from 2 hours to 15 minutes.</p>
            </div>
        </div>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <p class="box-subtitle">Test your knowledge of the gut-immune axis.</p>

            <div class="question-item">
                <p class="question-text">1. Which protein is responsible for the reversible opening of tight junctions, and what are its two primary triggers?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">The protein is <strong>Zonulin</strong>. Its two primary triggers are <strong>Gliadin</strong> (a component of gluten) and <strong>Bacterial Dysbiosis</strong> (specifically Gram-negative bacteria producing LPS).</div>
            </div>

            <div class="question-item">
                <p class="question-text">2. How does Butyrate support immune tolerance in autoimmune patients?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">Butyrate acts as an HDAC inhibitor that promotes the differentiation of <strong>T-regulatory (Treg) cells</strong>. These cells are essential for maintaining immune tolerance and suppressing the pro-inflammatory Th17 response.</div>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li>The gut barrier is the primary interface between the environment and the immune system; its failure (Leaky Gut) is a prerequisite for most autoimmune pathologies.</li>
                <li>LPS translocation (metabolic endotoxemia) triggers systemic inflammation through the TLR4/NF-ÎºB pathway.</li>
                <li>Restoring microbiome diversity is essential for SCFA production, which fuels colonocytes and balances immune cells.</li>
                <li>The 5-R Framework provides a clinical roadmap for reversing intestinal permeability and reducing the autoimmune inflammatory load.</li>
                <li>Successful autoimmune management requires addressing digestive mechanics (HCl, enzymes) and lifestyle (MMC, stress) alongside dietary changes.</li>
            </ul>
        </div>

        <div class="references-box">
            <p class="box-label">References & Further Reading</p>
            <p>1. Fasano, A. (2020). "All disease begins in the (leaky) gut: role of zonulin-mediated gut permeability in the pathogenesis of some chronic inflammatory diseases." <i>F1000Research</i>.</p>
            <p>2. Mu et al. (2017). "Leaky Gut as a Danger Signal for Autoimmune Diseases." <i>Frontiers in Immunology</i>.</p>
            <p>3. Zhang et al. (2021). "The Gut Microbiome and Systemic Lupus Erythematosus: A Meta-Analysis." <i>Journal of Autoimmunity</i>.</p>
            <p>4. Smith et al. (2022). "The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis." <i>Science</i>.</p>
            <p>5. Pimentel, M. et al. (2020). "The Microbiome and SIBO in Irritable Bowel Syndrome and Beyond." <i>Gastroenterology & Hepatology</i>.</p>
            <p>6. Arrieta et al. (2015). "Alterations in the intestinal microbiome and its impact on the development of autoimmune diseases." <i>Nature Reviews Rheumatology</i>.</p>
        </div>

        <footer class="lesson-footer">
            <img src="https://accredipro.com/wp-content/uploads/2023/05/AccrediPro-Logo-Horizontal-Gold-Black.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy: Autoimmune Specialist Certification</p>
            <p class="copyright">&copy; 2024 AccrediPro Academy. All rights reserved. Confidential Professional Certification Material.</p>
        </footer>
    </div>
</body>

</html>